Anemia due to iron deficiency is the most common in the world being characterized as a significant public health issue. Therefore, its prevention and treatment are considered important before it becomes either chronic or grievous; the interventions with superior potential are the medical supplementation with iron salts as well as food mineral enhancement. The objectives of this study were to develop fermented dairy beverages supplemented with iron and added by Cerrado fruit pulps: cagaita (Eugenia dysenterica), coquinho-azedo (Butia capitata), tamarindo (Tamarindus indica), and umbu (Spondias tuberosa). On addition, the research intended to evaluate the acceptance of these beverages by children and adolescents from public schools in the city of Montes Claros (MG). The methodology consisted in the production of dairy beverages followed by the evaluation of their quality through physicochemical and microbiological analyses. Posteriorly, children and adolescents assessed the sensorial acceptance. The analyses performed presented satisfactory results for physicochemical and microbiological properties regarding the acceptance of the product. The cagaita and coquinho azedo based dairy beverages were the most accepted whether compared with tamarindo and umbu beverages. The fermented dairy beverage supplemented with iron and added by Cerrado fruits come up as a feasible alternative for dietary supplementation, and can promote beneficial effects in human health due to their sensorial acceptance.

Autism Spectrum Disorder (ASD) is a series of neurological and behavioural complications that destabilize several characteristics of human development. Some patients require psychopharmacological treatment to control symptoms. When these drugs interfere negatively in quality of life, their use deserves special attention. The objective of this article was to verify the importance of the pharmaceutical professional in the monitoring of autistic children and adolescents in a group of autistics of the North of Minas Gerais Association of Support to the Autistic (ANDA). The pharmacotherapeutic profile was determined, and the incidence of medication-related problems was surveyed. For this, an anthropometric evaluation, blood glucose and cholesterol test and verification of adherence to treatment were performed. It was found that the monitoring of the autistic patient by the clinical pharmacist is of fundamental importance, focused on primary health care. The professional should monitor the appearance of dyslipidaemia and other metabolic disorders in autistic patients, especially those who use atypical antipsychotics and who have food selectivity, or motor dysfunction associated with autism.